Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

STAA Insider Trading

STAAR SURGICAL CO | Ophthalmic Goods

Comprehensive Trading Performance Summary

The investment history of corporate insiders at STAAR SURGICAL CO provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Ophthalmic Goods sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2019-03-22 23:11 2019-03-19 Holliday Keith Officer - Chief Technology Officer SELL $37.82 5,209 $197,014 37,114 -12.3%
2019-03-22 23:10 2019-03-19 Gesten Samuel J Officer - Chief Legal Officer SELL $37.61 3,188 $119,912 35,128 -8.3%
2019-03-22 23:11 2019-03-22 ANDREWS DEBORAH J Officer - Chief Financial Officer SELL $38.88 833 $32,387 37,268 -2.2%
2019-03-22 23:08 2019-03-19 Mason Caren L Director, Officer - President & CEO SELL $36.25 7,500 $271,875 44,013 -14.6%
2018-08-20 23:22 2018-08-20 Wall William P Director SELL $41.35 5,000 $206,750 16,235 -23.5%
2018-05-07 23:06 2018-05-03 ANDREWS DEBORAH J Officer - Chief Financial Officer OPT+S $17.60 13,331 $234,626 15,667 0.0%
2018-03-22 19:49 2018-03-22 Holliday Keith Officer - Chief Technology Officer SELL $16.03 2,188 $35,065 43,781 -4.8%
2018-03-22 19:47 2018-03-22 Gesten Samuel J Officer - Chief Legal Officer SELL $16.05 2,833 $45,470 38,316 -6.9%
2018-03-22 19:46 2018-03-22 ANDREWS DEBORAH J Officer - Chief Financial Officer SELL $16.05 333 $5,345 15,667 -2.1%
2018-03-21 23:25 2018-03-20 Holliday Keith Officer - Chief Technology Officer SELL $16.05 1,458 $23,401 45,969 -3.1%
2018-03-21 23:25 2018-03-19 Mason Caren L Director, Officer - President & CEO SELL $16.09 6,667 $107,272 51,513 -11.5%
2017-11-22 19:14 2017-11-21 Holliday Keith Officer - V.P., Chief Technology Officer SELL $16.65 6,000 $99,915 45,969 -11.5%
2016-12-10 01:20 2016-12-08 Blickensdoerfer Hans-Martin Officer - Sr. VP, EMEA, LA and China OPT+S $11.14 25,000 $278,478 116,700 0.0%
2016-07-01 00:00 2016-06-28 BROADWOOD PARTNERS LP 10% owner BUY $5.24 14,144 $74,081 10,855,179 +0.1%
2016-05-26 00:32 2016-05-23 BROADWOOD PARTNERS LP 10% owner BUY $5.16 77,842 $401,727 10,841,035 +0.7%
2016-05-23 17:37 2016-05-19 MEIER RICHARD A Director SELL $5.35 25,000 $133,850 18,300 -57.7%
2016-05-20 00:35 2016-05-17 BROADWOOD PARTNERS LP 10% owner BUY $5.23 9,313 $48,693 10,763,193 +0.1%
2016-05-17 00:56 2016-05-12 BROADWOOD PARTNERS LP 10% owner BUY $5.49 336,210 $1,847,440 10,753,880 +3.2%
2016-02-17 01:18 2016-02-11 BROADWOOD PARTNERS LP 10% owner BUY $6.01 554,066 $3,329,937 0 +100.0%
2016-02-17 03:00 2016-02-11 BROADWOOD PARTNERS LP 10% owner BUY $6.01 554,066 $3,329,937 10,417,670 +5.6%
2016-02-10 00:54 2016-02-05 BROADWOOD PARTNERS LP 10% owner BUY $6.25 91,770 $573,205 9,863,604 +0.9%
2016-02-05 01:04 2016-02-02 BROADWOOD PARTNERS LP 10% owner BUY $6.40 121,599 $778,817 9,771,834 +1.3%
2016-02-02 01:11 2016-01-28 BROADWOOD PARTNERS LP 10% owner BUY $6.48 65,983 $427,636 9,650,235 +0.7%
2016-01-28 01:59 2016-01-25 BROADWOOD PARTNERS LP 10% owner BUY $6.63 239,013 $1,585,803 9,584,252 +2.6%
2016-01-22 01:22 2016-01-19 BROADWOOD PARTNERS LP 10% owner BUY $6.75 72,858 $491,624 9,345,239 +0.8%
2016-01-16 01:13 2016-01-13 BROADWOOD PARTNERS LP 10% owner BUY $6.73 135,725 $913,185 9,272,381 +1.5%
2016-01-13 01:00 2016-01-08 BROADWOOD PARTNERS LP 10% owner BUY $6.83 86,586 $591,486 9,136,656 +1.0%
2016-01-08 02:29 2016-01-05 BROADWOOD PARTNERS LP 10% owner BUY $6.95 267,047 $1,856,083 9,050,070 +3.0%
2016-01-05 01:28 2015-12-30 BROADWOOD PARTNERS LP 10% owner BUY $7.11 165,461 $1,176,196 8,783,023 +1.9%
2015-09-30 01:32 2015-09-25 BROADWOOD PARTNERS LP 10% owner BUY $7.08 311,099 $2,203,763 8,617,562 +3.7%
2015-08-26 04:36 2015-08-24 Mason Caren L Director, Officer - President & CEO BUY $7.34 10,000 $73,420 14,500 +222.2%
2015-08-26 00:58 2015-08-21 BROADWOOD PARTNERS LP 10% owner BUY $7.17 188,881 $1,354,239 8,306,463 +2.3%
2015-08-11 23:41 2015-08-10 SILVERMAN LOU Director BUY $8.18 1,500 $12,273 6,398 +30.6%
2015-08-07 23:44 2015-08-06 ROUSH JACK STEVEN Director BUY $8.08 1,000 $8,080 1,000 +100.0%
2015-04-07 23:48 2015-04-06 Gesten Samuel J Officer - VP, General Counsel SELL $7.14 3,223 $23,014 22,485 -12.5%
2015-03-05 02:58 2014-03-20 Hughes Robin Officer - Vice President, R&D SELL $15.82 23,253 $367,918 19,575 -54.3%
2014-11-20 02:44 2014-11-17 BROADWOOD PARTNERS LP 10% owner BUY $8.64 189,646 $1,639,205 7,417,582 +2.6%
2014-11-13 01:52 2014-11-10 BROADWOOD PARTNERS LP 10% owner BUY $8.79 500 $4,395 7,227,936 +0.0%
2014-11-08 01:56 2014-11-05 BROADWOOD PARTNERS LP 10% owner BUY $8.92 80,000 $713,624 7,227,436 +1.1%
2014-11-05 01:55 2014-10-31 BROADWOOD PARTNERS LP 10% owner BUY $9.20 260,341 $2,394,252 7,147,436 +3.8%
2014-03-20 04:27 2014-03-19 Francese James E Officer - VP, Global Marketing OPT+S $17.22 16,666 $287,059 21,960 0.0%
2014-03-18 00:17 2014-03-13 Francese James E Officer - VP, Global Marketing SELL $14.90 4,540 $67,661 21,960 -17.1%
2014-03-18 00:17 2014-03-13 Gesten Samuel J Officer - VP, General Counsel SELL $14.91 1,890 $28,175 25,307 -6.9%
2014-03-18 00:17 2014-03-13 Hughes Robin Officer - Vice President, R&D SELL $16.61 5,672 $94,208 56,818 -9.1%
2013-11-16 02:18 2013-11-13 Hughes Robin Officer - Vice President, R&D SELL $12.83 29,053 $372,849 48,500 -37.5%
2013-11-13 00:32 2013-11-08 Hughes Robin Officer - Vice President, R&D SELL $13.00 947 $12,311 77,553 -1.2%
2013-09-04 23:16 2013-09-03 ANDREWS DEBORAH J Officer, Other - Vice President OPT+S $12.88 50,000 $643,805 36,400 0.0%
2013-08-22 23:34 2013-08-20 ANDREWS DEBORAH J Officer, Other - Vice President OPT+S $11.65 33,515 $390,450 36,400 0.0%
2013-08-20 02:50 2013-08-13 ANDREWS DEBORAH J Officer, Other - Vice President OPT+S $11.70 685 $8,014 36,400 0.0%
2013-08-20 02:49 2013-08-08 ANDREWS DEBORAH J Officer, Other - Vice President OPT+S $11.62 9,079 $105,530 36,400 0.0%
SHOW ENTRIES

How to Interpret $STAA Trades

Not every insider transaction in STAAR SURGICAL CO is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $STAA shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for STAA

Insider activity data for STAAR SURGICAL CO is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $STAA, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.